Furthermore, these mono- and dual-reactive T cells differed in expression of exhaustion markers PD1+LAG3+ and CD39 suggesting that these different subsets underwent different differentiation pathways in the tumor bed possibly contributing to progenitor- and terminal-exhaustion phenotypes (Fig. 6F–G). The gene discussed is LAG3; the disease is neoplasm.